| Literature DB >> 14622501 |
Anthony J Bella1, Gerald B Brock.
Abstract
Oral phosphodiesterase-5 inhibitors have emerged as the preferred first-line treatment for erectile dysfunction worldwide because of patient convenience, efficacy, and safety. Clinical trials have shown that tadalafil significantly enhances erectile function across a wide range of etiologies and provides a prolonged period of effectiveness independent of food or alcohol. In this review, the pharmacokinetic and pharmacodynamic characteristics, efficacy, and safety of tadalafil are discussed.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14622501 DOI: 10.1007/s11934-003-0029-8
Source DB: PubMed Journal: Curr Urol Rep ISSN: 1527-2737 Impact factor: 3.092